"Spółka Jagiellońskie Centrum Innowacji została powołana w 2004 r. przez Uniwersytet Jagielloński w Krakowie w celu budowy i zarządzania infrastrukturą Life Science Parku, a także zapewnienia szerokiego zestawu usług dla przedsiębiorców i naukowców rozwijających nauki przyrodnicze."

During the past decade, Jagiellońskie Centrum Innowacji Sp.z o.o. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jagiellońskie Centrum Innowacji Sp.z o.o." are "Influenza" (1 trials) and "Lesion in Body Region" (1 trials). Many other conditions were trialed in "Jagiellońskie Centrum Innowacji Sp.z o.o." in a lesser frequency.

Most popular intervention types in "Jagiellońskie Centrum Innowacji Sp.z o.o." are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gadobutrol 1 MMOLE/ML Intravenous Solution" (1 trials), "M-001" (1 trials), "Saline" (1 trials) and "gadopiclenol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jagiellońskie Centrum Innowacji Sp.z o.o." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jagiellońskie Centrum Innowacji Sp.z o.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jagiellońskie Centrum Innowacji Sp.z o.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jagiellońskie Centrum Innowacji Sp.z o.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".